Abstract
Introduction
Kaposi sarcoma (multiple idiopathic hemorrhagic sarcoma) is a neoplastic vascular disorder characterized by multiple violaceous nodules on the skin of the upper and lower extremities. 1 It can also aff ect the gastrointestinal tract, lymph nodes, spleen, pancreas, liver, adrenal glands, and larynx. 2 As the disease progresses, nodules may also appear on the mucosal membranes of the head and neck. However, Kaposi sarcoma is not routinely considered in the diff erential diagnosis of cutaneous or mucosal lesions in this region. 1 We describe a very rare case of primary nasopharyngeal Kaposi sarcoma in a patient with acquired immune defi ciency syndrome (AIDS).
Case report
A 37-year-old man presented with a 3-month history of recurrent epistaxis and postnasal hemorrhage. Th e primary site of the bleeding was the left nasal cavity. He had been diagnosed with AIDS 4 years earlier; he had no history of other serious disease. He denied smoking, alcohol abuse, and weight loss.
On physical examination, no skin lesions were evident on his face, neck, chest, or upper extremities. Likewise, no genital or anal ulcerations or other skin lesions were seen on the lower part of his body. No signifi cant cervical lymphadenopathy was detected. Endoscopic examination of the left nasal cavity revealed the presence of a bluish, smooth, fi rm, nonpulsatile 3-cm mass in the nasopharyngeal wall adjacent to the left Rosenmüller fossa (fi gure 1). Anterior rhinoscopy detected no abnormalities, and it failed to identify the source of the bleeding. Findings on the rest of the otorhinolaryngologic examination were normal. Magnetic resonance imaging (MRI) demonstrated a smoothly marginated mass in the posterior nasopharyngeal wall that had obliterated the left Rosenmüller fossa (fi gure 2).
An endoscopic biopsy of the mass was performed. On light microscopy, hematoxylin and eosin (H&E) staining revealed a cellular tumor made up of fascicles of spindle cells. Extravasated red blood cells were seen between the neoplastic cells and in dispersed, slit-like spaces (fi gure 3). Th e tumoral cells contained spindled nuclei with vesicular or coarse chromatin and small nucleoli. Immunohistochemically, the cells were diff usely positive for CD34, more focally positive for CD31 (fi gure 4, A), and diff usely positive for human herpesvirus-8 (HHV-8) (fi gure 4, B). Th ese fi ndings were consistent with Kaposi sarcoma.
Because the tumor originated in the nasopharynx, which is one of the most diffi cult sites to reach surgically, we chose to treat the patient with radiotherapy. He was irradiated with 6-MV x-rays from parallel opposed portals bilaterally. Treatment was administered from our knowledge, only 1 other case has been previously reported in the English-language literature. In that case, reported by Atkinson and Ptak in 1999, the oropharynx and hypopharynx were also involved. 9 AIDS-related Kaposi sarcoma is usually asymptomatic. Symptoms may appear when mucosal lesions become ulcerated or produce a local mass eff ect. 7 Mucosal AIDSrelated Kaposi sarcoma may manifest radiographically as diverse nodular lesions, usually without ulceration. MRI plays a major role in the diagnosis because of its superior soft -tissue diff erentiation. On MRI and computed tomography (CT), AIDS-related Kaposi sarcoma is characterized by a relatively strong tumoral enhancement aft er administration of contrast material. 7 Th e diff erential diagnosis of a nasopharyngeal Kaposi sarcoma includes lymphoid hyperplasia, carcinoma, angiofi broma, and cyst. In lymphoid hyperplasia, the signal intensity is similar to that of muscle on T1-weighted MRI. On T2-weighted MRI, lymphoid hyperplasia has a high signal intensity, and on contrast-enhanced MRI, conformal fi elds. Th e daily dose was 200 cGy, and the total dose was 4,000 cGy. Th e patient did not experience any serious complications associated with radiotherapy. At 12 months of follow-up, no signs of recurrence were evident.
Discussion
Kaposi sarcoma is a multifocal neoplastic lesion of multicentric origin. Metastasis is rare. 3 AIDS patients have shown a marked tendency to develop Kaposi sarcoma, yet the pathogenesis of AIDS-related Kaposi sarcoma remains unclear. 4 Th e possibility of a viral etiology has been suggested, and it has been reported that immunosuppression increases the risk of acquiring it. 5 Still, Kaposi sarcoma is 300 times more common in patients with AIDS than in other groups of immunosuppressed patients. 6 Head and neck involvement is common in Kaposi sarcoma. It generally occurs as a component of widespread generalized disease. Kaposi sarcoma may appear as a primary mucosal or cutaneous tumor of the head and neck. 1 Cutaneous involvement in the head neck region is present in 66% of cases, mucosal forms are seen in 56%, and enlarged lymph nodes are present in as many as 13%. 7 Th e oral cavity is involved in most cases of AIDS-related Kaposi sarcoma. 8 Other head and neck sites include the skin, oropharynx, tongue, hypopharynx, and larynx. In rare cases, the conjunctiva, lacrimal gland, parotid gland, masseter muscle, or tonsil is aff ected. Primary disease involving the nasopharynx in AIDS patients is extremely rare. In fact, to the best of 
. Endoscopic examination of the left nasal cavity shows the smooth, fi rm mass (KS) in the nasopharyngeal wall (NW) (NS = nasal septum).

Figure 2. Axial T2-weighted (A) and postcontrast T1-weighted (B) MRIs show the well-defi ned mass lesion (arrow) in the posterior nasopharyngeal wall obliterating the left Rosenmüller fossa. Th e lesion is hyperintense on the T2-weighted image, and it demonstrates homogeneous contrast enhancement on the T1-weighted image.
Figure 3. H&E staining shows hypercellular neoplasia consisting of spindle cells, slit-like spaces, and extravasated red blood cells.
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inhomogeneous enhancement may be seen secondary to fi brous tissue. Juvenile nasopharyngeal angiofi broma is a highly vascular, locally invasive lesion that occurs almost exclusively in adolescent boys. On MRI, this neoplasm demonstrates an intermediate signal intensity on T1-weighted imaging; in contrast, fat is relatively hyperintense and muscle is relatively hypointense. Nasopharyngeal carcinomas demonstrate a homogeneous signal intensity on MRI similar to that of the adjacent mucosa. Because nasopharyngeal cystic lesions generally do not enhance with contrast material on CT, MRI is the superior method in diff erentiating these lesions from the adjacent soft tissues. Nasopharyngeal cysts show a high signal intensity on both T1-and T2-weighted imaging, and they do not enhance with gadolinium contrast. On T2-weighted imaging, most nonvascularized neoplasms involving the nasopharynx demonstrate moderate to low signal intensity. Th e lesion in our patient was hyperintense on T2-weighted MRI, and it demonstrated homogeneous contrast enhancement on T1-weighted MRI. Histopathologically, Kaposi sarcoma progresses through three continuous stages: patch, plaque, and nodule. Each stage features distinctive gross and microscopic features. Th e patch stage is defi ned by a vascular proliferation dissecting the adjacent stroma. 10 Th e plaque and nodule stages are characterized by increasing numbers of spindle cells associated with numerous extravasated red blood cells and slit-like spaces. 10 Our patient was diagnosed with a nodule-stage lesion.
Kaposi sarcoma is considered to be of vascular origin, and in the diff erential diagnosis, the morphologic considerations encompass those of other vascular and mesenchymal neoplasms. Nasopharyngeal angiofi bromas feature thin-walled vessels in a collagenous fi brotic stroma, and they lack the hypercellular spindle component and dense vascular proliferation of Kaposi sarcoma.
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Other mesenchymal tumors-including smooth-muscle tumors, nerve-sheath tumors, sarcomatoid carcinomas and spindle cell variants of certain malignant tumors such as melanomas and angiosarcomas-must be kept in mind, even though they are rare; a panel of immunohistochemical markers should be applied. 12 In this context, HHV-8 has been shown to be associated with Kaposi sarcoma, and its immunohistochemical demonstration establishes the diagnosis of Kaposi sarcoma in the appropriate setting. 13, 14 Surgical excision, radiotherapy, and chemotherapy have all been used to treat Kaposi sarcoma. So have several novel options, including highly active antiretroviral therapy, molecularly targeted agents, and biologicresponse modifi ers such as interferon.
Radiotherapy is eff ective for treating localized tumors, and it has been used successfully in areas as diverse as the skin, oral cavity, lung, and conjunctiva. 15 One retrospective study of patients with AIDS-related Kaposi's sarcoma treated with radiotherapy found an objective response rate of 74%. 16 Chemotherapy has the potential to treat multifocal disease, but it can cause serious systemic side eff ects. Commonly used agents include vincristine, vinblastine, etoposide, bleomycin, and doxorubicin. Th ese agents have been used singly and in combination, and success rates have been variable.
Local treatment is usually more appropriate for localized lesions. For this purpose, intralesional chemotherapy, cryotherapy, laser treatment, photodynamic treatment, and excisional surgery have been used. Intralesional chemotherapy eliminates the risk 
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of immunosuppression that is associated with systemic chemotherapy. Vinblastine is possibly the most widely used intralesional chemotherapeutic agent. Th e response rate to vinblastine is very good-approximately 70%. 17 In fact, intralesional vinblastine has been found to be even more successful than systemic chemotherapy. 18 
